Roche's Tecentriq cocktail helps lung cancer patients live longer

ZURICH (Reuters) - Swiss drugmaker Roche's immunotherapy Tecentriq combined with other medicines helped people with advanced lung cancer live longer, compared to patients receiving an older drug combination, the company said in a statement on Monday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news